<DOC>
	<DOCNO>NCT02606110</DOCNO>
	<brief_summary>The purpose study investigate effect ReBuilder treatment individual breast cancer chemotherapy induce peripheral neuropathy .</brief_summary>
	<brief_title>Pilot Study Investigating Use ReBuilder Treat Chemotherapy Induced Peripheral Neuropathy Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Patients breast cancer refer Physical Therapy CIPN Physical Therapy Examination indicate use Rebuilder CIPN At least 18 year age Signed informed consent study population Willingness complete study accord protocol Patients CIPN Patients &lt; 18 year age Inability unwilling sign inform consent Unable read understand English language Preexisting sensory peripheral neuropathy comorbid condition diabetes alcoholism More three ( 3 ) prior ReBuilder treatment ; OR ReBuilder within last 30 day , sensory peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>ReBuilder</keyword>
	<keyword>breast cancer</keyword>
	<keyword>chemotherapy induce</keyword>
</DOC>